Movement Alert｜WuXi Biologics Rises 4.24% in Regular Trading, Consecutive Buybacks and Sector Momentum Lift Share Price

Market Focus06-24

On June 24, WuXi Biologics rose 4.24% in regular trading, trading at HKD 32.18/share, with turnover of HKD 128 million.

On the news front, the company has conducted buybacks for three consecutive trading days. From June 18 to June 23, WuXi Biologics repurchased a total of 6.465 million shares at an aggregate cost of approximately HKD 199 million, during which the share price accumulated a gain of 4.29%. Year-to-date, the company has executed 14 rounds of buybacks totaling 34.218 million shares worth HKD 1.072 billion, signaling sustained confidence from management in the company's intrinsic value.

Meanwhile, the Life Sciences Tools and Services sector showed broad-based strength. Among sector peers, GenScript Biotech rose 6.53%, WuXi XDC rose 6.43%, and WuXi AppTec rose 4.28%, reflecting significant sector resonance. Multiple brokerages including CITIC Securities and Guotai Haitong Securities maintain Buy ratings with target prices ranging from HKD 48 to HKD 54.49, well above the current trading level.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1183673571?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 09:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183673571","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi Biologics Rises 4.24% in Regular Trading, Consecutive Buybacks and Sector Momentum Lift Share Price","media":"Market Focus","content":"<p><p>On June 24, WuXi Biologics rose 4.24% in regular trading, trading at HKD 32.18/share, with turnover of HKD 128 million.</p><p>On the news front, the company has conducted buybacks for three consecutive trading days. From June 18 to June 23, WuXi Biologics repurchased a total of 6.465 million shares at an aggregate cost of approximately HKD 199 million, during which the share price accumulated a gain of 4.29%. Year-to-date, the company has executed 14 rounds of buybacks totaling 34.218 million shares worth HKD 1.072 billion, signaling sustained confidence from management in the company's intrinsic value.</p><p>Meanwhile, the Life Sciences Tools and Services sector showed broad-based strength. Among sector peers, GenScript Biotech rose 6.53%, WuXi XDC rose 6.43%, and WuXi AppTec rose 4.28%, reflecting significant sector resonance. Multiple brokerages including CITIC Securities and Guotai Haitong Securities maintain Buy ratings with target prices ranging from HKD 48 to HKD 54.49, well above the current trading level.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi Biologics Rises 4.24% in Regular Trading, Consecutive Buybacks and Sector Momentum Lift Share Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi Biologics Rises 4.24% in Regular Trading, Consecutive Buybacks and Sector Momentum Lift Share Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-24 09:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 24, WuXi Biologics rose 4.24% in regular trading, trading at HKD 32.18/share, with turnover of HKD 128 million.</p><p>On the news front, the company has conducted buybacks for three consecutive trading days. From June 18 to June 23, WuXi Biologics repurchased a total of 6.465 million shares at an aggregate cost of approximately HKD 199 million, during which the share price accumulated a gain of 4.29%. Year-to-date, the company has executed 14 rounds of buybacks totaling 34.218 million shares worth HKD 1.072 billion, signaling sustained confidence from management in the company's intrinsic value.</p><p>Meanwhile, the Life Sciences Tools and Services sector showed broad-based strength. Among sector peers, GenScript Biotech rose 6.53%, WuXi XDC rose 6.43%, and WuXi AppTec rose 4.28%, reflecting significant sector resonance. Multiple brokerages including CITIC Securities and Guotai Haitong Securities maintain Buy ratings with target prices ranging from HKD 48 to HKD 54.49, well above the current trading level.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1183673571","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183673571","pubTimestamp":1782265520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 24, WuXi Biologics rose 4.24% in regular trading, trading at HKD 32.18/share, with turnover of HKD 128 million.On the news front, the company has conducted buybacks for three consecutive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"动向提示|药明生物常规交易涨4.24%连续回购板块动能提振股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"On June 24, WuXi Biologics rose 4.24% in regular trading, trading at HKD 32.18/share, with turnover of HKD 128 million.On the news front, the company has conducted buybacks for three consecutive trading days. From June 18 to June 23, WuXi Biologics repurchased a total of 6.465 million shares at an aggregate cost of approximately HKD 199 million, during which the share price accumulated a gain of 4.29%. Year-to-date, the company has executed 14 rounds of buybacks totaling 34.218 million shares worth HKD 1.072 billion, signaling sustained confidence from management in the company's intrinsic value.Meanwhile, the Life Sciences Tools and Services sector showed broad-based strength. Among sector peers, GenScript Biotech rose 6.53%, WuXi XDC rose 6.43%, and WuXi AppTec rose 4.28%, reflecting significant sector resonance. Multiple brokerages including CITIC Securities and Guotai Haitong Securities maintain Buy ratings with target prices ranging from HKD 48 to HKD 54.49, well above the current trading level.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1183673571","isCrawlerRequest":true}